PURCHASE AGREEMENT by and among KIRIN SD, INC. and ADVANCED CELL TECHNOLOGY, INC. As of May 9, 2006Purchase Agreement • August 11th, 2006 • Advanced Cell Technology, Inc. • Pharmaceutical preparations • New York
This PURCHASE AGREEMENT, dated as of May 9, 2006 (together with the exhibits attached hereto, this “Agreement”), is entered into by and between Kirin SD, Inc., a Delaware corporation (the “Purchaser”), and Advanced Cell Technology, Inc., a Delaware corporation (“ACT”). Certain capitalized terms used in this Agreement are defined on Exhibit A attached hereto.
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • August 11th, 2006 • Advanced Cell Technology, Inc. • Pharmaceutical preparations • Massachusetts
This Exclusive License Agreement (“Agreement”), effective as of May 9, 2006 (the “Effective Date”), is between Kirin Beer Kabushiki Kaisha, a Japanese corporation with offices located at 10-1, Shinkawa 2-Chome, Chuo-Ku, Tokyo, Japan 104-8288 (“Kirin”), and any of its subsidiaries, including Aurox, LLC, a Delaware limited liability company (“Aurox”), Hematech, LLC, a Delaware limited liability company (“Hematech”), and Kirin SD, Inc., a Delaware corporation, (“Kirin SD”), all with offices located at Hamlet Professional Building, 4001 Valhalla Boulevard, Suite 103, Sioux Falls, SD 57106, (Kirin, Aurox, Hematech and Kirin SD referred to collectively herein as “Licensor”), and Advanced Cell Technology, Inc., a Delaware corporation with offices located at 1201 Harbor Bay Parkway, Suite 120, Alameda, California 94502 (“ACT” or “Licensee”) (Licensee and Licensor sometimes hereinafter referred to individually as a “Party” and collectively as the “Parties”).
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • August 11th, 2006 • Advanced Cell Technology, Inc. • Pharmaceutical preparations • Massachusetts
This Non-Exclusive License Agreement (“Agreement”), effective as of May 9, 2006 (the “Effective Date”), is between Advanced Cell Technology, Inc., a Delaware corporation with offices located at 381 Plantation Street, Worcester, Massachusetts 01605 (“ACT” or “Licensor), and Kirin Beer Kabushiki Kaisha, a Japanese corporation with offices located at 10 1, Shinkawa 2 chome, Chuo-ku, Tokyo, Japan 104 8288 (“Kirin”) and any of its subsidiaries, including Aurox, LLC, a Delaware limited liability company (“Aurox”), Hematech, LLC, a Delaware limited liability company (“Hematech”), and Kirin SD, Inc., a Delaware corporation (“Kirin SD”), all with offices located at Hamlet Professional Building, 4001 Valhalla Boulevard, Suite 103, Sioux Falls, SD 57106 (Kirin, Aurox, Hematech, and Kirin SD referred to collectively herein as “Licensee”) (Licensor and Licensee sometimes hereinafter referred to individually as a “Party” and collectively as the “Parties”).
